These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 12565976)
1. Organic phenyl arsonic acid compounds with potent antileukemic activity. Liu XP; Narla RK; Uckun FM Bioorg Med Chem Lett; 2003 Feb; 13(3):581-3. PubMed ID: 12565976 [TBL] [Abstract][Full Text] [Related]
2. Phenylarsonic acid compounds with broad-spectrum and potent cytotoxic activity against human cancer cells. Uckun FM; D'Cruz OJ; Liu XP; Narla RK Arzneimittelforschung; 2003; 53(6):428-39. PubMed ID: 12872614 [TBL] [Abstract][Full Text] [Related]
3. Cysteine chloromethyl and diazomethyl ketone derivatives with potent anti-leukemic activity. Perrey DA; Narla RK; Uckun FM Bioorg Med Chem Lett; 2000 Mar; 10(6):547-9. PubMed ID: 10741550 [TBL] [Abstract][Full Text] [Related]
4. The S-alkyl chain length as a determinant of the anti-leukemic activity of cysteine chloromethyl ketone compounds. Perrey DA; Scannell MP; Narla RK; Uckun FM Bioorg Med Chem Lett; 2000 Mar; 10(6):551-2. PubMed ID: 10741551 [TBL] [Abstract][Full Text] [Related]
5. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. Sudbeck EA; Liu XP; Narla RK; Mahajan S; Ghosh S; Mao C; Uckun FM Clin Cancer Res; 1999 Jun; 5(6):1569-82. PubMed ID: 10389946 [TBL] [Abstract][Full Text] [Related]
6. N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes. O'Donnell PH; Guo WX; Reynolds CP; Maurer BJ Leukemia; 2002 May; 16(5):902-10. PubMed ID: 11986953 [TBL] [Abstract][Full Text] [Related]
7. Thermal sensitivity and thermal tolerance of human B-lineage acute lymphoblastic leukemia (ALL) cells. Min WS; Song CW; Uckun FM Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):147-53. PubMed ID: 2298618 [TBL] [Abstract][Full Text] [Related]
8. Human sperm immobilizing activity of aminophenyl arsenic acid and its N-substituted quinazoline, pyrimidine, and purine derivatives: protective effect of glutathione. Uckun FM; Liu XP; D'Cruz OJ Reprod Toxicol; 2002; 16(1):57-64. PubMed ID: 11934532 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, cytotoxicity, and antitumor activity of copper(II) and iron(II) complexes of (4)N-azabicyclo[3.2.2]nonane thiosemicarbazones derived from acyl diazines. Easmon J; Pürstinger G; Heinisch G; Roth T; Fiebig HH; Holzer W; Jäger W; Jenny M; Hofmann J J Med Chem; 2001 Jun; 44(13):2164-71. PubMed ID: 11405653 [TBL] [Abstract][Full Text] [Related]
10. [Organoarsenicals derived from 2-phenyl-[1,3,2]dithiarsolan-4-yl)-methanol (AsIII) with antileukaemic properties: from trypanosomicides to anticancer drugs]. Gibaud S; Astier A Ann Pharm Fr; 2007 May; 65(3):162-8. PubMed ID: 17489071 [TBL] [Abstract][Full Text] [Related]
11. Antileukemic activity and cellular metabolism of the aryl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07). Uckun FM; Tai HL; D'Cruz OJ Arzneimittelforschung; 2005; 55(1):50-65. PubMed ID: 15727164 [TBL] [Abstract][Full Text] [Related]
12. PQJS380: a novel lead compound to induce apoptosis in acute lymphoblastic leukemia cells. Zhu X; Chen L; Jiang S; Chen C; Yao Y; Chen D; Xue H; Pan J Cancer Biol Ther; 2014 Jan; 15(1):119-27. PubMed ID: 24253322 [TBL] [Abstract][Full Text] [Related]
13. Classification of Congeneric and QSAR of Homologous Antileukemic Castellano G; León A; Torrens F Molecules; 2021 Jan; 26(1):. PubMed ID: 33466352 [TBL] [Abstract][Full Text] [Related]
14. Antileukemic activity of an arsenomolybdate in the human HL-60 and U937 leukemia cells. Li C; Cao H; Sun J; Tian R; Li D; Qi Y; Yang W; Li J J Inorg Biochem; 2017 Mar; 168():67-75. PubMed ID: 28013066 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Kaspers GJ; Veerman AJ; Popp-Snijders C; Lomecky M; Van Zantwijk CH; Swinkels LM; Van Wering ER; Pieters R Med Pediatr Oncol; 1996 Aug; 27(2):114-21. PubMed ID: 8649318 [TBL] [Abstract][Full Text] [Related]
16. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(I.V.) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity. Narla RK; Dong Y; Klis D; Uckun FM Clin Cancer Res; 2001 Apr; 7(4):1094-101. PubMed ID: 11309362 [TBL] [Abstract][Full Text] [Related]
17. Antileukemic activity of aminoparthenolide analogs. Nasim S; Crooks PA Bioorg Med Chem Lett; 2008 Jul; 18(14):3870-3. PubMed ID: 18590961 [TBL] [Abstract][Full Text] [Related]
18. Anti-proliferative and anti-leukemic activity of DDE46 (compound WHI-07), a novel bromomethoxylated arylphosphate derivative of zidovudine, and related compounds. Studies using human acute lymphoblastic leukemia cells and the zebrafish model. Benyumov AO; Venkatachalam TK; Grigoriants OO; Vassilev AO; Tibbles HE; Downs S; Dumezb D; Uckun FM Arzneimittelforschung; 2005; 55(2):114-22. PubMed ID: 15787279 [TBL] [Abstract][Full Text] [Related]
19. Cytostatic and cytotoxic activity of sex steroids against human leukemia cell lines. Blagosklonny MV; Neckers LM Cancer Lett; 1994 Jan; 76(2-3):81-6. PubMed ID: 8149350 [TBL] [Abstract][Full Text] [Related]
20. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells. Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]